Applied Genetic Technologies adds $11.8M round to its DNA

Applied Genetic Technologies Corp., a clinical stage biotechnology company has closed on an $11,800,000 financing round led by InterWest Partners of Menlo Park, CA. Other participants in the round include Intersouth Partners and MedImmune Ventures Inc.... [more]

View complete TechJournal South article